Parkinson’s disease, a progressive neurodegenerative disorder, is emerging as a significant health challenge in the United States and globally, primarily due to an aging population. This condition, characterized by motor symptoms such as tremors, muscle rigidity, and slowed movement, along with numerous non-motor symptoms, reduces quality of life and affects independence. According to DelveInsight’s analysis, more than 1 million people in the United States alone are diagnosed with Parkinson’s disease, with nearly 3 million patients across the seven major markets, including the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan. This widespread...